Australia, March 4 -- Incyte Holdings Corp., owns the trademark (2508129) for 'NIKTIMVO' and 'DROP,OBLIQUE,NOTCHED' till Oct. 29, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders.], 16 [Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.] and 44 [Providing a medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic and dermatological disorders.]
Type of Mark: Figurative
Date of Acceptance: Dec. 23, 2024
Registration Advertised: March 3
For further details contact Frances M. Jagla Christensen O'Connor Johnson Kindness.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2508129.
Disclaimer: Curated by HT Syndication.
